Lakeshore Biopharma Co, Stock Probability of Future Stock Price Finishing Over 34.62

LSBPW Stock   0.04  0  2.83%   
LakeShore Biopharma's future price is the expected price of LakeShore Biopharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of LakeShore Biopharma Co, performance during a given time horizon utilizing its historical volatility. Check out LakeShore Biopharma Backtesting, LakeShore Biopharma Valuation, LakeShore Biopharma Correlation, LakeShore Biopharma Hype Analysis, LakeShore Biopharma Volatility, LakeShore Biopharma History as well as LakeShore Biopharma Performance.
  
Please specify LakeShore Biopharma's target price for which you would like LakeShore Biopharma odds to be computed.

LakeShore Biopharma Target Price Odds to finish over 34.62

The tendency of LakeShore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over  34.62  or more in 90 days
 0.04 90 days 34.62 
close to zero percent
Based on a normal probability distribution, the odds of LakeShore Biopharma to move over  34.62  or more in 90 days from now is close to zero percent (This LakeShore Biopharma Co, probability density function shows the probability of LakeShore Stock to fall within a particular range of prices over 90 days) . Probability of LakeShore Biopharma Co, price to stay between its current price of  0.04  and  34.62  at the end of the 90-day period is more than 94.0 .
Assuming the 90 days horizon LakeShore Biopharma Co, has a beta of -0.66. This indicates as returns on the benchmark increase, returns on holding LakeShore Biopharma are expected to decrease at a much lower rate. During a bear market, however, LakeShore Biopharma Co, is likely to outperform the market. Additionally LakeShore Biopharma Co, has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   LakeShore Biopharma Price Density   
       Price  

Predictive Modules for LakeShore Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma Co,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0411.56
Details
Intrinsic
Valuation
LowRealHigh
0.000.0411.56
Details
Naive
Forecast
LowNextHigh
0.00080.0411.56
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.060.08
Details

LakeShore Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. LakeShore Biopharma is not an exception. The market had few large corrections towards the LakeShore Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LakeShore Biopharma Co,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LakeShore Biopharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.69
β
Beta against Dow Jones-0.66
σ
Overall volatility
0.01
Ir
Information ratio -0.07

LakeShore Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LakeShore Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LakeShore Biopharma Co, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
LakeShore Biopharma generated a negative expected return over the last 90 days
LakeShore Biopharma has high historical volatility and very poor performance
LakeShore Biopharma has some characteristics of a very speculative penny stock
LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years
LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YSBPW.
The company reported the revenue of 573.42 M. Net Loss for the year was (433.46 M) with profit before overhead, payroll, taxes, and interest of 0.
LakeShore Biopharma generates negative cash flow from operations

LakeShore Biopharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LakeShore Stock often depends not only on the future outlook of the current and potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding188.3 M
Cash And Short Term Investments246.4 M

LakeShore Biopharma Technical Analysis

LakeShore Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. LakeShore Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LakeShore Biopharma Co,. In general, you should focus on analyzing LakeShore Stock price patterns and their correlations with different microeconomic environments and drivers.

LakeShore Biopharma Predictive Forecast Models

LakeShore Biopharma's time-series forecasting models is one of many LakeShore Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LakeShore Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about LakeShore Biopharma Co,

Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LakeShore Biopharma Co, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LakeShore Biopharma generated a negative expected return over the last 90 days
LakeShore Biopharma has high historical volatility and very poor performance
LakeShore Biopharma has some characteristics of a very speculative penny stock
LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years
LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YSBPW.
The company reported the revenue of 573.42 M. Net Loss for the year was (433.46 M) with profit before overhead, payroll, taxes, and interest of 0.
LakeShore Biopharma generates negative cash flow from operations

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.